Increased lipid profiles that counterbalanced the down-regulated effect of decreased BMI on PAI-1 levels might therefore be the main driving force for increased PAI-1 levels in CHC patients after SVR. The gene discussed is SERPINE1; the disease is cryohydrocytosis.